| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |